Trial
NCT05376319
PR3-AAV Resilient Remission or PRRR
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
Genentech, Inc.
Condition
Granulomatosis With Polyangiitis
Intervention
Obinutuzumab
Why stopped
Funding was withdrawn by sponsor.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-06